“PREEKLAMPSIYA KUZATILGAN HOMILADORLARDA AKUSHERLIK VA PERINATAL ASORATLARNI PROGNOZLASH”.
Ключевые слова:
preeklampsiya, homiladorlik, akusherlik va perinatal asoratlar, prognozlash, davolash.Аннотация
Preeklampsiya kuzatilgan homiladorlarda biokimyoviy va gemostaziologik markyorlarning miqdorini aniqlash va shunga ko‘ra, homiladorlarda akusherlik va perinatal asoratlar rivojlanishini prognozlash.
Библиографические ссылки
“Homiladorlik davrida arterial gipertenziyani olib borish bo‘yicha milliy klinik bayonnoma ” 22.03.2021 yil;
WHO U, UNFPA, World Bank Group and the United Nations Population Division, author, Trends in Maternal Mortality 2000 to 2017.2019;
“Onalar va bolalar salomatligini muhofaza qilish, aholining reproduktiv salomatligini mustahkamlash chora-tadbirlari to‘g‘risida” PQ-296-son 08/09/2023
Alisse Hauspurg, MD; Arun Jeyabalan, MD “Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy” American Journal of Obstetrics & Gynecology S1211-1221 FEBRUARY 2022
L.Saleh; M.M.Alblas; D.Nieboer; R.I.Neuman; Y.Vergouwe; I.A.Brusse ; J.J.Duvekot ; E.W.Steyerberg; H.J.Versendaal ; A.H.Danser; A.H.Van Den Meiracker; K.Verdonk; W.Visser. “Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model” Ultrasound Obstet Gynecol 2021; 58; 698-704
S.R.Adizova “Preeklampsiya asoratlarni bashoratlashda biokimyoviy markerlarning klinik ahamiyati” Doktor axborotnomasi №4(108)-2022
Opichka, M.A.; Rappelt, M.W.; Gutterman, D.D.; Grobe, J.L.; McIntosh, J.J. Vascular Dysfunction in Preeclampsia. Cells 2021, 10, 3055.
Eunjung JUNG, MD, Roberto ROMERO, MD, DMedSci1, Lami YEO, MD, Nardhy GOMEZ-LOPEZ, PhD, Piya CHAEMSAITHONG, MD, PhD, Adithep JAOVISIDHA, MD, Offer EREZ, MD” The etiology of preeclampsia” Am J Obstet Gynecol. 2022 February; 226(2 Suppl): S844–S866. doi:10.1016/j.ajog.2021.11.1356.
Curr. Issues Mol. Biol. 2023, 45, 6202–6215. Sara Tabacco, Silvia Ambrosii, Valentina Polsinelli, Ilaria Fantasia, Angela D’Alfonso, Manuela Ludovisi, Sandra Cecconi, and Maurizio Guido “Pre-Eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools—A Review of the Literature” Curr. Issues Mol. Biol. 2023, 45, 6202–6215.
Mol, B.W.J.; Roberts, C.T.; Thangaratinam, S.; Magee, L.A.; de Groot, C.J.M.; Hofmeyr, G.J. Pre-Eclampsia. Lancet 2016, 387, 999–1011.
Portelli, M.; Baron, B. Clinical presentation of preeclampsia and the diagnostic value of proteins and their methylation productsas biomarkers in pregnant women with preeclampsia and their newborns. J. Pregnancy 2018, 2018, 2632637.
Rana, S.; Lemoine, E.; Granger, J.P.; Karumanchi, S.A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res.2019, 124, 1094–1112.
Herraiz, I.; Llurba, E.; Verlohren, S.; Galindo, A.; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the SFlt-1/PlGF Ratio in Singleton Pregnancies. Fetal Diagn. Ther.2018, 43, 81–89.
Loudon, I. Some historical aspects of toxaemia of pregnancy. A Rev. BJOG 1991, 98, 853–858.
Lai, J.; Romero, R.; Tarca, A.L.; Iliodromiti, S.; Rehal, A.; Banerjee, A.; Yu, C.; Peeva, G.; Palaniappan, V.; Tan, L. SARS-COV-2 and the subsequent development of preeclampsia and preterm birth: Evidence of a dose response relationship supporting causality.Am. J. Obstet. Gynecol. 2021, 225, 689–693.
Conde-Agudelo, A.; Villar, J.; Lindheimer, M. Maternal infection and risk of preeclampsia: Systematic review and metaanalysis.Am. J. Obestet. Gynecol. 2008, 198, 7–22.
Easter, S.R.; Cantonwine, D.E.; Zera, C.A.; Lim, K.H.; Parry, S.I.; McElrath, T.F. Urinary tract infection during pregnancy,
angiogenic factor profiles, and risk of preeclampsia. Am. J. Obestet. Gynecol. 2016, 214, 387.e1–387.e7.
Tambyah, P.A.; Maki, D.G. Catheter-associated urinary tract infection is rarely symptomatic: A prospective study of 1497
catheterized patients. Arch. Intern. Med. 2000, 160, 678–682.
Herraiz, I.; Llurba, E.; Verlohren, S.; Galindo, A.; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the SFlt-1/PlGF Ratio in Singleton Pregnancies. Fetal Diagn. Ther.2018, 43, 81–89.
LaMarca, B.D.; Ryan, M.J.; Gilbert, J.S.; Murphy, S.R.; Granger, J.P. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep. 2007, 9, 480–485.
Sutton, E.F.; Lob, H.E.; Song, J.; Xia, Y.; Butler, S.; Liu, C.-C.; Redman, L.M.; Sones, J.L. Adverse metabolic phenotype of female offspring exposed to preeclampsia in utero: A characterization of the BPH/5 mouse in postnatal life. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017, 312, R485–R491.
Schneider, S.; Freerksen, N.; Röhrig, S.; Hoeft, B.; Maul, H. Gestational diabetes and preeclampsia—Similar risk factor profiles Early Hum. Dev. 2012, 88, 179–184.
Rachael Fox, Jamie Kitt, Paul Leeson, Christina YL Aye, Adam J Lewandowski “Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring” J Clin Med. 2019 Oct 4;8(10):1625
V. TSATSARIS (Paris) “Preeclampsia: Update on epidemiologic parameters, etiology and management”
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005 Jun 10;308(5728):1592-4.
Акушерство: национальное руководство / под ред. Г. М. Савельевой, Г. Т. Сухих, В. Н. Серова, В. Е. Радзинского. - 2-е изд, перераб. и доп. - М.: ГЭОТАР-Медиа, 2018. - 1088 с. - (Серия, “Национальные руководства”). - ISBN 978-5-9704-4551-8.
Alisse Hauspurg, MD; Arun Jeyabalan, MD “Postpartum preeclampsia or eclampsia:defining its place and management among the hypertensive disorders of pregnancy”.
